COVID-19 Impact : Our analysts have covered special segments related to COVID-19 to help prepare detailed reports about the current developments within the global markets and have studied and identified the potential growth opportunities, strategies to manage and navigate the markets according to the current flow of the market to help facilitate business processes. Our primary goal is to help businesses maintain their competitive edge in the markets and to aim to provide necessary information to help them maintain their status-quo within their organizations.

Speak to Analyst

Global Newcastle Disease Vaccine Market Insights, Forecast to 2025

Report Code: AMR- 1-26961

Category: Pharma & Healthcare

Published Date: 2019-04-22

Format: Electronic PDF

Pages: 110

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.

The global Newcastle Disease Vaccine market is valued at 280 million US$ in 2018 and will reach 360 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Newcastle Disease Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Newcastle Disease Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Newcastle Disease Vaccine in these regions.
This research report categorizes the global Newcastle Disease Vaccine market by top players/brands, region, type and end user. This report also studies the global Newcastle Disease Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo

Market size by Product
Live Vaccines
Killed Vaccines
Market size by End User
Chicken
Duck & Goose
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Newcastle Disease Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Newcastle Disease Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Newcastle Disease Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Newcastle Disease Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Newcastle Disease Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Newcastle Disease Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
    1.1  Newcastle Disease Vaccine Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Newcastle Disease Vaccine Market Size Growth Rate by Product
        1.4.2 Live Vaccines
        1.4.3 Killed Vaccines
    1.5 Market by End User
        1.5.1 Global Newcastle Disease Vaccine Market Size Growth Rate by End User
        1.5.2 Chicken
        1.5.3 Duck & Goose
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Newcastle Disease Vaccine Market Size
        2.1.1 Global Newcastle Disease Vaccine Revenue 2014-2025
        2.1.2 Global Newcastle Disease Vaccine Sales 2014-2025
    2.2 Newcastle Disease Vaccine Growth Rate by Regions
        2.2.1 Global Newcastle Disease Vaccine Sales by Regions
        2.2.2 Global Newcastle Disease Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Newcastle Disease Vaccine Sales by Manufacturers
        3.1.1 Newcastle Disease Vaccine Sales by Manufacturers
        3.1.2 Newcastle Disease Vaccine Sales Market Share by Manufacturers
        3.1.3 Global Newcastle Disease Vaccine Market Concentration Ratio (CR5 and HHI)
    3.2 Newcastle Disease Vaccine Revenue by Manufacturers
        3.2.1 Newcastle Disease Vaccine Revenue by Manufacturers (2014-2019)
        3.2.2 Newcastle Disease Vaccine Revenue Share by Manufacturers (2014-2019)
    3.3 Newcastle Disease Vaccine Price by Manufacturers
    3.4 Newcastle Disease Vaccine Manufacturing Base Distribution, Product Types
        3.4.1 Newcastle Disease Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Newcastle Disease Vaccine Product Type
        3.4.3 Date of International Manufacturers Enter into Newcastle Disease Vaccine  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Newcastle Disease Vaccine Sales by Product
    4.2 Global Newcastle Disease Vaccine Revenue by Product
    4.3 Newcastle Disease Vaccine Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Newcastle Disease Vaccine Breakdown Data by End User

6 North America
    6.1 North America Newcastle Disease Vaccine by Countries
        6.1.1 North America Newcastle Disease Vaccine Sales by Countries
        6.1.2 North America Newcastle Disease Vaccine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Newcastle Disease Vaccine by Product
    6.3 North America Newcastle Disease Vaccine by End User

7 Europe
    7.1 Europe Newcastle Disease Vaccine by Countries
        7.1.1 Europe Newcastle Disease Vaccine Sales by Countries
        7.1.2 Europe Newcastle Disease Vaccine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Newcastle Disease Vaccine by Product
    7.3 Europe Newcastle Disease Vaccine by End User

8 Asia Pacific
    8.1 Asia Pacific Newcastle Disease Vaccine by Countries
        8.1.1 Asia Pacific Newcastle Disease Vaccine Sales by Countries
        8.1.2 Asia Pacific Newcastle Disease Vaccine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Newcastle Disease Vaccine by Product
    8.3 Asia Pacific Newcastle Disease Vaccine by End User

9 Central & South America
    9.1 Central & South America Newcastle Disease Vaccine by Countries
        9.1.1 Central & South America Newcastle Disease Vaccine Sales by Countries
        9.1.2 Central & South America Newcastle Disease Vaccine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Newcastle Disease Vaccine by Product
    9.3 Central & South America Newcastle Disease Vaccine by End User

10 Middle East and Africa
    10.1 Middle East and Africa Newcastle Disease Vaccine by Countries
        10.1.1 Middle East and Africa Newcastle Disease Vaccine Sales by Countries
        10.1.2 Middle East and Africa Newcastle Disease Vaccine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Newcastle Disease Vaccine by Product
    10.3 Middle East and Africa Newcastle Disease Vaccine by End User

11 Company Profiles
    11.1 Merial
        11.1.1 Merial Company Details
        11.1.2 Company Business Overview
        11.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Merial Newcastle Disease Vaccine Products Offered
        11.1.5 Merial Recent Development
    11.2 CEVA
        11.2.1 CEVA Company Details
        11.2.2 Company Business Overview
        11.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 CEVA Newcastle Disease Vaccine Products Offered
        11.2.5 CEVA Recent Development
    11.3 QYH Biotech
        11.3.1 QYH Biotech Company Details
        11.3.2 Company Business Overview
        11.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 QYH Biotech Newcastle Disease Vaccine Products Offered
        11.3.5 QYH Biotech Recent Development
    11.4 Ringpu Biology
        11.4.1 Ringpu Biology Company Details
        11.4.2 Company Business Overview
        11.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Ringpu Biology Newcastle Disease Vaccine Products Offered
        11.4.5 Ringpu Biology Recent Development
    11.5 Yebio
        11.5.1 Yebio Company Details
        11.5.2 Company Business Overview
        11.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Yebio Newcastle Disease Vaccine Products Offered
        11.5.5 Yebio Recent Development
    11.6 Harbin Veterinary Research Institute
        11.6.1 Harbin Veterinary Research Institute Company Details
        11.6.2 Company Business Overview
        11.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Products Offered
        11.6.5 Harbin Veterinary Research Institute Recent Development
    11.7 Merck Animal Health
        11.7.1 Merck Animal Health Company Details
        11.7.2 Company Business Overview
        11.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Merck Animal Health Newcastle Disease Vaccine Products Offered
        11.7.5 Merck Animal Health Recent Development
    11.8 DHN
        11.8.1 DHN Company Details
        11.8.2 Company Business Overview
        11.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 DHN Newcastle Disease Vaccine Products Offered
        11.8.5 DHN Recent Development
    11.9 Zoetis
        11.9.1 Zoetis Company Details
        11.9.2 Company Business Overview
        11.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Zoetis Newcastle Disease Vaccine Products Offered
        11.9.5 Zoetis Recent Development
    11.10 ChengDu Tecbond
        11.10.1 ChengDu Tecbond Company Details
        11.10.2 Company Business Overview
        11.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 ChengDu Tecbond Newcastle Disease Vaccine Products Offered
        11.10.5 ChengDu Tecbond Recent Development
    11.11 Elanco (Lohmann)
    11.12 FATRO
    11.13 CAVAC
    11.14 Vaksindo

12 Future Forecast
    12.1 Newcastle Disease Vaccine Market Forecast by Regions
        12.1.1 Global Newcastle Disease Vaccine Sales Forecast by Regions 2019-2025
        12.1.2 Global Newcastle Disease Vaccine Revenue Forecast by Regions 2019-2025
    12.2 Newcastle Disease Vaccine Market Forecast by Product
        12.2.1 Global Newcastle Disease Vaccine Sales Forecast by Product 2019-2025
        12.2.2 Global Newcastle Disease Vaccine Revenue Forecast by Product 2019-2025
    12.3 Newcastle Disease Vaccine Market Forecast by End User
    12.4 North America Newcastle Disease Vaccine Forecast
    12.5 Europe Newcastle Disease Vaccine Forecast
    12.6 Asia Pacific Newcastle Disease Vaccine Forecast
    12.7 Central & South America Newcastle Disease Vaccine Forecast
    12.8 Middle East and Africa Newcastle Disease Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Newcastle Disease Vaccine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures

    Figure Newcastle Disease Vaccine Product Picture
    Table Newcastle Disease Vaccine Market Segments
    Table Key Manufacturers Newcastle Disease Vaccine Covered
    Table Global Newcastle Disease Vaccine Market Size Growth Rate by Product 2019-2025 (M Doses) & (Million US$)
    Figure Global Newcastle Disease Vaccine Sales Market Share by Product 2014-2025
    Figure Live Vaccines Product Picture
    Table Major Manufacturers of Live Vaccines
    Figure Killed Vaccines Product Picture
    Table Major Manufacturers of Killed Vaccines
    Table Global Newcastle Disease Vaccine Market Size Growth Rate by End User 2019-2025 (M Doses)
    Figure Chicken
    Figure Duck & Goose
    Figure Other
    Figure Newcastle Disease Vaccine Report Years Considered
    Figure Global Newcastle Disease Vaccine Market Size 2014-2025 (Million US$)
    Figure Global Newcastle Disease Vaccine Sales 2014-2025 (M Doses)
    Table Global Newcastle Disease Vaccine Market Size by Regions 2014-2019 (M Doses) & (Million US$)
    Table Global Newcastle Disease Vaccine Sales by Regions 2014-2019 (M Doses)
    Table Global Newcastle Disease Vaccine Sales Market Share by Regions 2014-2019
    Figure Global Newcastle Disease Vaccine Sales Market Share by Regions 2014-2019
    Figure 2018 Global Newcastle Disease Vaccine Sales Market Share by Regions
    Table Global Newcastle Disease Vaccine Revenue by Regions 2014-2019 (Million US$)
    Table Global Newcastle Disease Vaccine Revenue Market Share by Regions 2014-2019
    Figure Global Newcastle Disease Vaccine Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Newcastle Disease Vaccine Revenue Market Share by Regions
    Table Global Newcastle Disease Vaccine Sales by Manufacturers (2014-2019) (M Doses)
    Table Global Newcastle Disease Vaccine Sales Share by Manufacturers (2014-2019)
    Figure Global Newcastle Disease Vaccine Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Newcastle Disease Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
    Table Newcastle Disease Vaccine Revenue Share by Manufacturers (2014-2019)
    Figure Newcastle Disease Vaccine Value Share by Manufacturers in 2018
    Table Key Manufacturers Newcastle Disease Vaccine Price (2014-2019) (USD/K Doses)
    Table Newcastle Disease Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Newcastle Disease Vaccine Product Type
    Table Date of International Manufacturers Enter into Newcastle Disease Vaccine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Newcastle Disease Vaccine Sales by Product (2014-2019) (M Doses)
    Table Global Newcastle Disease Vaccine Sales Share by Product (2014-2019)
    Figure Global Newcastle Disease Vaccine Sales Market Share by Product (2014-2019)
    Figure Global Newcastle Disease Vaccine Sales Market Share by Product in 2018
    Table Global Newcastle Disease Vaccine Revenue by Product (2014-2019) (Million US$)
    Table Global Newcastle Disease Vaccine Revenue Share by Product (2014-2019)
    Figure Global Newcastle Disease Vaccine Revenue Market Share by Product (2014-2019)
    Figure Global Newcastle Disease Vaccine Revenue Market Share by Product in 2018
    Table Newcastle Disease Vaccine Price by Product 2014-2019 (USD/K Doses)
    Table Global Newcastle Disease Vaccine Sales by End User (2014-2019) (M Doses)
    Table Global Newcastle Disease Vaccine Sales Share by End User (2014-2019)
    Figure Global Sales Newcastle Disease Vaccine Market Share by End User (2014-2019)
    Figure Global Sales Newcastle Disease Vaccine Market Share by End User in 2018
    Figure North America Newcastle Disease Vaccine Sales Growth Rate 2014-2019 (M Doses)
    Figure North America Newcastle Disease Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Newcastle Disease Vaccine Sales by Countries (2014-2019) (M Doses)
    Table North America Newcastle Disease Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Newcastle Disease Vaccine Sales Market Share by Countries
    Table North America Newcastle Disease Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table North America Newcastle Disease Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Newcastle Disease Vaccine Revenue Market Share by Countries
    Figure United States Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure United States Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (M Doses)
    Figure Canada Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Canada Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Mexico Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Newcastle Disease Vaccine Sales by Product (2014-2019) (M Doses)
    Table North America Newcastle Disease Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 North America Newcastle Disease Vaccine Market Share by Product
    Table North America Newcastle Disease Vaccine Sales by End User (2014-2019) (M Doses)
    Table North America Newcastle Disease Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 North America Newcastle Disease Vaccine Market Share by End User
    Figure Europe Newcastle Disease Vaccine Sales Growth Rate 2014-2019 (M Doses)
    Figure Europe Newcastle Disease Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Newcastle Disease Vaccine Sales by Countries (2014-2019) (M Doses)
    Table Europe Newcastle Disease Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Newcastle Disease Vaccine Sales Market Share by Countries
    Table Europe Newcastle Disease Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Europe Newcastle Disease Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Newcastle Disease Vaccine Revenue Market Share by Countries
    Figure Germany Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Germany Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure France Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure UK Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Italy Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Russia Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Newcastle Disease Vaccine Sales by Product (2014-2019) (M Doses)
    Table Europe Newcastle Disease Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Newcastle Disease Vaccine Market Share by Product
    Table Europe Newcastle Disease Vaccine Sales by End User (2014-2019) (M Doses)
    Table Europe Newcastle Disease Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Newcastle Disease Vaccine Market Share by End User
    Figure Asia Pacific Newcastle Disease Vaccine Sales Growth Rate 2014-2019 (M Doses)
    Figure Asia Pacific Newcastle Disease Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Newcastle Disease Vaccine Sales by Countries (2014-2019) (M Doses)
    Table Asia Pacific Newcastle Disease Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Newcastle Disease Vaccine Sales Market Share by Countries
    Table Asia Pacific Newcastle Disease Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Countries
    Figure China Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure China Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Japan Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Korea Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure India Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Australia Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Indonesia Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Malaysia Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Philippines Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Thailand Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Vietnam Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Singapore Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Newcastle Disease Vaccine Sales by Product (2014-2019) (M Doses)
    Table Asia Pacific Newcastle Disease Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Newcastle Disease Vaccine Market Share by Product
    Table Asia Pacific Newcastle Disease Vaccine Sales by End User (2014-2019) (M Doses)
    Table Asia Pacific Newcastle Disease Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Newcastle Disease Vaccine Market Share by End User
    Figure Central & South America Newcastle Disease Vaccine Sales Growth Rate 2014-2019 (M Doses)
    Figure Central & South America Newcastle Disease Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Newcastle Disease Vaccine Sales by Countries (2014-2019) (M Doses)
    Table Central & South America Newcastle Disease Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Newcastle Disease Vaccine Sales Market Share by Countries
    Table Central & South America Newcastle Disease Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Newcastle Disease Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Newcastle Disease Vaccine Revenue Market Share by Countries
    Figure Brazil Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Brazil Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Argentina Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Newcastle Disease Vaccine Sales by Product (2014-2019) (M Doses)
    Table Central & South America Newcastle Disease Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Newcastle Disease Vaccine Market Share by Product
    Table Central & South America Newcastle Disease Vaccine Sales by End User (2014-2019) (M Doses)
    Table Central & South America Newcastle Disease Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Newcastle Disease Vaccine Market Share by End User
    Figure Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate 2014-2019 (M Doses)
    Figure Middle East and Africa Newcastle Disease Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Newcastle Disease Vaccine Sales by Countries (2014-2019) (M Doses)
    Table Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Countries
    Table Middle East and Africa Newcastle Disease Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Countries
    Figure GCC Countries Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure GCC Countries Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Turkey Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure Egypt Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Newcastle Disease Vaccine Sales Growth Rate (2014-2019) (M Doses)
    Figure South Africa Newcastle Disease Vaccine Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Newcastle Disease Vaccine Sales by Product (2014-2019) (M Doses)
    Table Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Newcastle Disease Vaccine Market Share by Product
    Table Middle East and Africa Newcastle Disease Vaccine Sales by End User (2014-2019) (M Doses)
    Table Middle East and Africa Newcastle Disease Vaccine Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Newcastle Disease Vaccine Market Share by End User
    Table Merial Company Details
    Table Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table Merial Recent Development

    Table CEVA Company Details
    Table CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table CEVA Recent Development

    Table QYH Biotech Company Details
    Table QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table QYH Biotech Recent Development

    Table Ringpu Biology Company Details
    Table Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table Ringpu Biology Recent Development

    Table Yebio Company Details
    Table Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table Yebio Recent Development

    Table Harbin Veterinary Research Institute Company Details
    Table Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table Harbin Veterinary Research Institute Recent Development

    Table Merck Animal Health Company Details
    Table Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table Merck Animal Health Recent Development

    Table DHN Company Details
    Table DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table DHN Recent Development

    Table Zoetis Company Details
    Table Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table Zoetis Recent Development

    Table ChengDu Tecbond Company Details
    Table ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2014-2019)
    Table ChengDu Tecbond Recent Development

    Table Elanco (Lohmann) Company Details
    Table FATRO Company Details
    Table CAVAC Company Details
    Table Vaksindo Company Details
    Table Global Newcastle Disease Vaccine Sales Forecast by Regions 2019-2025 (M Doses)
    Table Global Newcastle Disease Vaccine Sales Market Share Forecast by Regions 2019-2025
    Table Global Newcastle Disease Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Newcastle Disease Vaccine Revenue Market Share Forecast by Regions 2019-2025
    Table Global Newcastle Disease Vaccine Sales Forecast by Product 2019-2025 (M Doses)
    Table Global Newcastle Disease Vaccine Sales Market Share Forecast by Product 2019-2025
    Table Global Newcastle Disease Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Newcastle Disease Vaccine Revenue Market Share Forecast by Product 2019-2025
    Table Global Newcastle Disease Vaccine Sales Forecast by End User 2019-2025 (M Doses)
    Table Global Newcastle Disease Vaccine Sales Market Share Forecast by End User 2019-2025
    Figure North America Newcastle Disease Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
    Figure North America Newcastle Disease Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Newcastle Disease Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
    Figure Europe Newcastle Disease Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Newcastle Disease Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
    Figure Asia Pacific Newcastle Disease Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Newcastle Disease Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
    Figure Central & South America Newcastle Disease Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
    Figure Middle East and Africa Newcastle Disease Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Newcastle Disease Vaccine Value Chain
    Table Newcastle Disease Vaccine Customers List
    Table Newcastle Disease Vaccine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Invalid Input

Global Newcastle Disease Vaccine Market Insights, Forecast to 2025

Purchase Now

Purchase Now